18, 2024 — Fatty liver, which can lead to liver damage and ... levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings suggest that the response ...
Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...